相似文献
1
Growth hormone treatment in a child with X-linked hypophosphataemic rickets.
Med J Armed Forces India. 2011 Oct;67(4):359-61. doi: 10.1016/S0377-1237(11)60085-3. Epub 2011 Oct 22.
2
Windswept lower limb deformities in patients with hypophosphataemic rickets.
Swiss Med Wkly. 2013 Dec 6;143:w13904. doi: 10.4414/smw.2013.13904. eCollection 2013.
3
Review of the dental implications of X-linked hypophosphataemic rickets (XLHR).
Clin Oral Investig. 2015 May;19(4):759-68. doi: 10.1007/s00784-015-1425-4. Epub 2015 Feb 13.
4
Genetic linkage studies of X-linked hypophosphataemic rickets in a Saudi Arabian family.
Clin Endocrinol (Oxf). 1992 Oct;37(4):338-43. doi: 10.1111/j.1365-2265.1992.tb02335.x.
5
Craniosynostosis in X-linked hypophosphataemic rickets.
J Paediatr Child Health. 1997 Feb;33(1):78-9. doi: 10.1111/j.1440-1754.1997.tb00997.x.
6
Hypophosphataemic rickets.
Horm Res. 2000;53 Suppl 3:57-60. doi: 10.1159/000023535.
7
Burosumab treatment of children with X-linked hypophosphataemic rickets.
Lancet. 2019 Jun 15;393(10189):2364-2366. doi: 10.1016/S0140-6736(19)31054-2. Epub 2019 May 16.
8
Treatment of hypophosphataemic vitamin D-resistant rickets and adult presenting hypophosphataemic vitamin D-resistant osteomalacia.
Int Orthop. 1980;3(4):257-64. doi: 10.1007/BF00266019.
9
Growth hormone and hypophosphataemic rickets.
Arch Dis Child. 1995 Jun;72(6):543-4. doi: 10.1136/adc.72.6.543-c.
10
Acquired hypophosphataemic vitamin D resistant rickets in black children.
Bone Miner. 1986 Sep;1(4):307-19.
本文引用的文献
1
Metabolic control and growth during exclusive growth hormone treatment in X-linked hypophosphatemic rickets.
Horm Res. 2008;69(4):212-20. doi: 10.1159/000113021. Epub 2008 Jan 21.
2
Growth in X-linked hypophosphatemic rickets.
Eur J Pediatr. 2007 Apr;166(4):303-9. doi: 10.1007/s00431-006-0357-z. Epub 2006 Dec 14.
3
Evaluation of stature development during childhood and adolescence in individuals with familial hypophosphatemic rickets.
ScientificWorldJournal. 2005 Oct 17;5:868-73. doi: 10.1100/tsw.2005.102.
4
Effects of growth hormone treatment on body proportions and final height among small children with X-linked hypophosphatemic rickets.
Pediatrics. 2004 Jun;113(6):e593-6. doi: 10.1542/peds.113.6.e593.
5
A genetic study of familial hypophosphatemia and vitamin D resistant rickets with a review of the literature.
Medicine (Baltimore). 1958 May;37(2):97-142. doi: 10.1097/00005792-195805000-00001.
6
Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets.
J Clin Endocrinol Metab. 2003 Aug;88(8):3591-7. doi: 10.1210/jc.2003-030036.
7
Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets.
Clin Endocrinol (Oxf). 2003 Feb;58(2):163-8. doi: 10.1046/j.1365-2265.2003.01685.x.
8
Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets.
J Pediatr. 2001 Feb;138(2):236-43. doi: 10.1067/mpd.2001.108955.
9
Growth hormone and hypophosphatemic rickets.
J Pediatr Endocrinol Metab. 2000 Sep;13 Suppl 2:993-8.
10
Phex cDNA cloning from rat bone and studies on phex mRNA expression: tissue-specificity, age-dependency, and regulation by insulin-like growth factor (IGF) I in vivo.
Mol Cell Endocrinol. 2000 Oct 25;168(1-2):41-51. doi: 10.1016/s0303-7207(00)00310-5.
Zotero 插件